Regencell Bioscience Holdings (RGC) Invested Capital (2020 - 2025)

Regencell Bioscience Holdings (RGC) has reported Invested Capital for 6 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $4.9 million, down 40.89% from the prior year.
• Invested Capital declined to $1.2 million in Q4 2025 per RGC's latest filing, from $4.9 million in the prior quarter.
• Across five years, Invested Capital topped out at $17.1 million in Q2 2022 and bottomed at -$315668.0 in Q2 2021.
• Historically, Invested Capital has averaged $7.2 million across 5 years, with a median of $6.5 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Invested Capital sank 175.34% in 2021, then jumped 5520.94% in 2022.
• Over 5 years, Invested Capital stood at -$315668.0 in 2021, then surged by 5520.94% to $17.1 million in 2022, then slipped by 29.87% to $12.0 million in 2023, then slumped by 31.44% to $8.2 million in 2024, then sank by 85.18% to $1.2 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $1.2 million, $4.9 million, and $8.2 million for Q4 2025, Q2 2025, and Q2 2024 respectively.